Concorde Asset Management’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,058
Closed -$230K 187
2021
Q4
$230K Hold
5,058
0.14% 148
2021
Q3
$220K Hold
5,058
0.13% 172
2021
Q2
$233K Sell
5,058
-22
-0.4% -$1.02K 0.13% 163
2021
Q1
$226K Hold
5,080
0.13% 187
2020
Q4
$202K Buy
+5,080
New +$189K 0.11% 143
2018
Q3
Sell
-5,058
Closed -$203K 150
2018
Q2
$203K Buy
+5,058
New +$187K 0.23% 118

Other funds holding NEOG

Concorde Asset Management's NEOG Position: Q1 2022 in Review

Concorde Asset Management sold out of Neogen (NEOG) in Q1 2022, closing a stake of 5,058 shares — an estimated $230K sold.

Concorde Asset Management first reported a position in NEOG in Q2 2018 and held it in 6 quarters. The position peaked at $233K in Q2 2021. 317 funds tracked by Wall St. Rank hold NEOG as of Q1 2022.

  • Concorde Asset Management reported no remaining Neogen position as of Q1 2022 after selling out during the quarter.
  • Concorde Asset Management sold 5,058 Neogen shares in Q1 2022, an estimated $230K.
  • Concorde Asset Management first reported a position in Neogen in Q2 2018 and held it in 6 quarters.
  • Concorde Asset Management's Neogen position peaked at $233K in Q2 2021.
  • 317 funds tracked by Wall St. Rank held Neogen as of Q1 2022.

Based on Concorde Asset Management's 13F filing for Q1 2022, filed 22 Apr 2022.